Literature DB >> 33177924

The Effect of Therapeutic Plasma Exchange on COVID-19 Therapy.

Cansu GÖncÜoĞlu1, Fatma Nisa Balli1, Aygin Bayraktar EkİncİoĞlu1.   

Abstract

Entities:  

Keywords:  COVID-19 treatment; drug removal; pharmacokinetic; therapeutic plasma exchange

Year:  2020        PMID： 33177924      PMCID： PMC7650731          DOI： 10.4274/tjps.galenos.2020.13845

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN： 1304-530X


× No keyword cloud information.
  8 in total

Review 1.  Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.

Authors:  Eva Schrezenmeier; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2020-02-07       Impact factor: 20.543

2.  Case Report: Use of Plasma Exchange Followed by Convalescent Plasma Therapy in a Critically Ill Patient with Severe Fever and Thrombocytopenia Syndrome-Associated Encephalopathy: Cytokine/Chemokine Concentrations, Viral Loads, and Antibody Responses.

Authors:  Sungim Choi; Min-Chul Kim; Ji-Soo Kwon; Ji-Yeun Kim; Keun Hwa Lee; Sung-Han Kim
Journal:  Am J Trop Med Hyg       Date:  2018-09-27       Impact factor: 2.345

3.  Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.

Authors:  S J Szefler; W F Ebling; J W Georgitis; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Plasma exchange and interferon-alpha pharmacokinetics in patients with hepatitis C virus-associated systemic vasculitis.

Authors:  P Hausfater; P Cacoub; U Assogba; P Lebon; J C Piette
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

5.  Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans.

Authors:  Pan Deng; Dafang Zhong; Kate Yu; Yifan Zhang; Ting Wang; Xiaoyan Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

Review 6.  Therapeutic Plasma Exchange and Its Impact on Drug Levels: An ACLPS Critical Review.

Authors:  Caleb W Cheng; Jeanne E Hendrickson; Christopher A Tormey; Davinder Sidhu
Journal:  Am J Clin Pathol       Date:  2017-09-01       Impact factor: 2.493

7.  Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.

Authors:  Thi Huyen Tram Nguyen; Jérémie Guedj; Xavier Anglaret; Cédric Laouénan; Vincent Madelain; Anne-Marie Taburet; Sylvain Baize; Daouda Sissoko; Boris Pastorino; Anne Rodallec; Géraldine Piorkowski; Sara Carazo; Mamoudou N Conde; Jean-Luc Gala; Joseph Akoi Bore; Caroline Carbonnelle; Frédéric Jacquot; Hervé Raoul; Denis Malvy; Xavier de Lamballerie; France Mentré
Journal:  PLoS Negl Trop Dis       Date:  2017-02-23

Review 8.  Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Authors:  Bingwen Liu; Min Li; Zhiguang Zhou; Xuan Guan; Yufei Xiang
Journal:  J Autoimmun       Date:  2020-04-10       Impact factor: 7.094
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.